Table 1 β-catenin and BRAF mutational status of tumor and age of 15 ACP patient cohort used in transcriptome study
From: Identification of targets for rational pharmacological therapy in childhood craniopharyngioma
UPN | β-Catenin | BRAF | Age at Dx |
|---|---|---|---|
411 | S33F | WT | 2 |
463 | S37F | WT | 4 |
598 | S37C | WT | 18 |
646 | D32N | WT | 7 |
673 | S37F | WT | 2 |
740 | S33F | WT | 12 |
802 | WT | WT | 7 |
883 | WT | WT | 6 |
956 | S37C | WT | 9 |
980 | D32N | WT | 13 |
1000 | S45F | WT | 0 |
9109 | WT | WT | 9 |
9201 | T41I | WT | - |
9202 | T41I | WT | - |
9302 | WT | WT | - |